Steven Cohen Curis Inc Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $3.33 Million - $7.4 Million	-1,442,543 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.45 - $8.09 $1.27 Million - $2.31 Million	285,800 Added 24.71%	1,442,543 $6.87 Million
Q3 2021 Nov 15, 2021	SELL	$6.94 - $8.85 $27.7 Million - $35.3 Million	-3,990,400 Reduced 77.53%	1,156,743 $9.06 Million
Q2 2021 Aug 16, 2021	SELL	$7.45 - $16.27 $3.52 Million - $7.7 Million	-473,148 Reduced 8.42%	5,147,143 $41.5 Million
Q1 2021 May 17, 2021	BUY	$8.78 - $12.8 $23.4 Million - $34.2 Million	2,670,291 Added 90.52%	5,620,291 $63.6 Million
Q4 2020 Feb 16, 2021	BUY	$1.08 - $8.2 $3.19 Million - $24.2 Million	2,950,000 New	2,950,000 $24.2 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.